返回
Hua Medicine (Shanghai) Ltd.（02552.HK）價格
02552.HK 股價走勢圖
HUA MEDICINE-B (02552.HK)
Hua Medicine (Shanghai) Ltd.
HK$3.25
-4.69%
$-0.16
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$3.41
開盤價
$3.41
當日範圍
$3.2 - $3.41
52週區間
$1.24 - $4.95
交易量
5.3M
平均成交量
3.5M
每股盈餘 (TTM)
1.21
股息收益率
--
市值
$3.2B
什麼是 HUA MEDICINE-B？
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.
